Reports
Reports
Sale
The global regenerative medicine market attained a value of USD 3.90 million in 2023 and is expected to grow at a CAGR of 11.7% during the forecast period of 2024-2032 owing to increased investment by companies in R&D.
Regenerative Medicine Drugs Market Size
Regenerative Medicine Drugs Analysis
Regenerative Medicine Drugs Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Regenerative Medicine Market Analysis
8.1 Key Industry Highlights
8.2 Global Regenerative Medicine Historical Market (2018-2023)
8.3 Global Regenerative Medicine Market Forecast (2024-2032)
8.4 Global Regenerative Medicine Market by Technology
8.4.1 Stem Cell Therapy
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Biomaterials
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Tissue Engineering
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.4 Others
8.5 Global Regenerative Medicine Market by Application
8.5.1 Bone Graft Substitutes
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Osteoarticular Diseases
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Dermatology
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Cardiovascular
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Central Nervous System
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
8.5.6 Others
8.6 Global Regenerative Medicine Market by Region
8.6.1 North America
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Europe
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Asia Pacific
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Latin America
8.6.4.1 Historical Trend (2018-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Middle East and Africa
8.6.5.1 Historical Trend (2018-2023)
8.6.5.2 Forecast Trend (2024-2032)
9 North America Regenerative Medicine Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Regenerative Medicine Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Regenerative Medicine Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Regenerative Medicine Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Regenerative Medicine Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Company Profiles
17.2.1 Novartis AG
17.2.1.1 Company Overview
17.2.1.2 Product Portfolio
17.2.1.3 Demographic Reach and Achievements
17.2.1.4 Certifications
17.2.2 Vericel Corporation
17.2.2.1 Company Overview
17.2.2.2 Product Portfolio
17.2.2.3 Demographic Reach and Achievements
17.2.2.4 Certifications
17.2.3 Stryker Corporation
17.2.3.1 Company Overview
17.2.3.2 Product Portfolio
17.2.3.3 Demographic Reach and Achievements
17.2.3.4 Certifications
17.2.4 Integra LifeSciences Corporation.
17.2.4.1 Company Overview
17.2.4.2 Product Portfolio
17.2.4.3 Demographic Reach and Achievements
17.2.4.4 Certifications
17.2.5 Mimedx Group Inc.
17.2.5.1 Company Overview
17.2.5.2 Product Portfolio
17.2.5.3 Demographic Reach and Achievements
17.2.5.4 Certifications
17.2.6 Wright Medical Group N.V.
17.2.6.1 Company Overview
17.2.6.2 Product Portfolio
17.2.6.3 Demographic Reach and Achievements
17.2.6.4 Certifications
17.2.7 Others
18 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Regenerative Medicine Market: Key Industry Highlights, 2018 and 2032
2. Global Regenerative Medicine Historical Market: Breakup by Technology (USD Million), 2018-2023
3. Global Regenerative Medicine Market Forecast: Breakup by Technology (USD Million), 2024-2032
4. Global Regenerative Medicine Historical Market: Breakup by Application (USD Million), 2018-2023
5. Global Regenerative Medicine Market Forecast: Breakup by Application (USD Million), 2024-2032
6. Global Regenerative Medicine Historical Market: Breakup by Region (USD Million), 2018-2023
7. Global Regenerative Medicine Market Forecast: Breakup by Region (USD Million), 2024-2032
8. North America Regenerative Medicine Historical Market: Breakup by Country (USD Million), 2018-2023
9. North America Regenerative Medicine Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Europe Regenerative Medicine Historical Market: Breakup by Country (USD Million), 2018-2023
11. Europe Regenerative Medicine Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Asia Pacific Regenerative Medicine Historical Market: Breakup by Country (USD Million), 2018-2023
13. Asia Pacific Regenerative Medicine Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Latin America Regenerative Medicine Historical Market: Breakup by Country (USD Million), 2018-2023
15. Latin America Regenerative Medicine Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Middle East and Africa Regenerative Medicine Historical Market: Breakup by Country (USD Million), 2018-2023
17. Middle East and Africa Regenerative Medicine Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Global Regenerative Medicine Market Structure
In 2023, the global regenerative medicine market attained a value of nearly USD 3.90 million.
The market is projected to grow at a CAGR of 11.7% between 2024 and 2032.
The major drivers of the industry such as emerging uses of gene therapy, rising prevalence of chronic diseases and genetic disorders, favourable government policies, and increased funding from various organisations are aiding the industry growth.
The key market trends guiding the growth of the industry include technological advancements in the field of stem cell, tissue engineering, and nanotechnology and high number of clinical trials.
The major regional markets are North America, Europe, the Asia Pacific, Latin America and the Middle East and Africa.
Stem cell therapy, biomaterial, and tissue engineering, among others are the major technologies of industry.
Bone graft substitutes, osteoarticular diseases, dermatology, cardiovascular, and central nervous system, among others are the major applications of regenerative medicine.
The major players in the industry are Novartis AG, Vericel Corporation, Stryker Corporation, Integra Lifesciences Corporation, Mimedx Group Inc., Wright Medical, Others.
The global regenerative medicine market attained a value of USD 3.90 million in 2023 driven by the increasing number of clinical trials. Aided by technological advancements in biotechnology and nanotechnology, and favourable government policies, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 11.7%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on technology, the industry can be segmented into stem cell therapy, biomaterial, and tissue engineering, among others. On the basis of application, the industry can be segmented into bone graft substitutes, osteoarticular diseases, dermatology, cardiovascular, and central nervous system, among others. The major regional markets for the industry are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Novartis AG, Vericel Corporation, Stryker Corporation, Integra Lifesciences Corporation, Mimedx Group Inc., Wright Medical, Others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.